Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma.

While PD-L1 expression has not completely correlated with therapeutic activity to checkpoint blockade in melanoma, this may be significant when considering other cancers where PD-L1 expression may be important for clinical activity with checkpoint blockade.

also in 13,097 other papers